Bon Natural Life Limited

BON ·Healthcare, Drug Manufacturers - General, China
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $6.3M $80.5K $112.8K $840.9K $1.9M $49.7K
Accounts Receivable $11.0M $11.8M $4.6M $6.8M $6.2M $5.8M
Inventory $3.3M $1.6M $987.3K $1.7M $1.6M $1.0M
Total Current Assets $45.8M $39.8M $24.2M $14.7M $16.5M $10.8M
Property, Plant & Equipment $18.2M $15.0M $15.5M $21.6M $19.2M $14.2M
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) $6.4M $777.0K $766.4K $366.2K $411.1K $141.0K
Total Assets $85.2M $61.8M $46.6M $37.3M $36.4M $25.2M
Liabilities
Accounts Payable $7.6M $3.4M $1.4M $214.6K $380.4K $1.3M
Total Current Liabilities $26.3M $16.4M $9.6M $6.6M $7.5M $11.7M
Long-Term Debt $842.8K $970.1K $871.4K $189.8K $2.2M $2.5M
Total Liabilities $27.2M $17.4M $10.6M $7.2M $9.9M $14.2M
Stockholders' Equity
Retained Earnings $16.6M $18.7M $18.7M $14.7M $9.2M $5.1M
Total Stockholders' Equity $57.6M $43.9M $35.5M $29.6M $26.0M $10.5M